TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive New Policy on Minor Changes in Trials Requires Halt in Patient Enrollment. April 25, 2008
TCL Archive Most Older Men With Early Prostate Cancer Can Avoid Treatment, Analysis Finds February 29, 2008